Hemodynamic effects of carbon dioxide pneumoperitoneum during mechanical ventilation and positive end-expiratory pressure.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 8411287)

Published in J Trauma on October 01, 1993

Authors

S M Moffa1, J V Quinn, G J Slotman

Author Affiliations

1: Department of Surgery, Cooper Hospital/University Medical Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden.

Articles by these authors

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Evaluation and management of traumatic lacerations. N Engl J Med (1997) 4.92

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1989) 3.41

Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med (1992) 2.99

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med (1994) 2.66

Randomized double-blind controlled trial comparing room-temperature and heated lidocaine for digital nerve block. Ann Emerg Med (1995) 1.68

Effect of advance directives on the management of elderly critically ill patients. Crit Care Med (1998) 1.43

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest (1987) 1.43

Prospective, randomized, controlled trial of tissue adhesive (2-octylcyanoacrylate) vs standard wound closure techniques for laceration repair. Stony Brook Octylcyanoacrylate Study Group. Acad Emerg Med (1998) 1.43

Multivariate regression modeling for the prediction of inflammation, systemic pressure, and end-organ function in severe sepsis. Shock (1997) 1.42

Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Crit Care Med (1999) 1.39

Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. J Pediatr (1995) 1.37

A prospective comparison of octylcyanoacrylate tissue adhesive and suture for the closure of head and neck incisions. J Otolaryngol (1997) 1.18

A new tissue adhesive for laceration repair in children. J Pediatr (1998) 1.17

Use of radiography in acute knee injuries: need for clinical decision rules. Acad Emerg Med (1995) 1.10

A randomized, clinical trial comparing butylcyanoacrylate with octylcyanoacrylate in the management of selected pediatric facial lacerations. Acad Emerg Med (1999) 1.09

Staphylococcus epidermidis sepsis in surgical patients. Arch Surg (1984) 1.08

Enterococcal bacteremia in surgical patients. Arch Surg (1985) 1.07

Fungal sepsis in surgical patients. Arch Surg (1983) 1.04

Enterobacter bacteremia in surgical patients. Surgery (1986) 1.03

Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg (1987) 1.00

Tissue adhesive wound repair revisited. J Emerg Med (1995) 0.95

Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery (1986) 0.94

Head and neck cancer in a young age group: high incidence in black patients. Head Neck Surg (1983) 0.90

The health management of cyclone Tracy. Med J Aust (1975) 0.90

Alteration of postischemic renal pathology by prostaglandin infusion. J Surg Res (1980) 0.88

Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. Circ Shock (1985) 0.87

Patterns of complementary and alternative medicine use in ED patients and its association with health care utilization. Am J Emerg Med (2004) 0.85

Effect of prostaglandin E1 and steroid combination in the treatment of hemorrhagic shock. Adv Shock Res (1978) 0.82

The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer (1984) 0.82

Adverse effects of hypothermia in postoperative patients. Am J Surg (1985) 0.81

Decompression after gastric surgery. Gastrostomy versus nasogastric tube. Am Surg (1989) 0.80

Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. Shock (1996) 0.80

Interleukin-1 mediates increased plasma levels of eicosanoids and cytokines in patients with sepsis syndrome. Shock (1995) 0.80

Comparison of the hemodynamic effects of gasless abdominal distention and CO2 pneumoperitoneum during incremental positive end-expiratory pressure. J Surg Res (1995) 0.79

Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion. Surgery (1982) 0.79

The hemodynamic effects of prostaglandin E1 (PGE1) in acute hypoxic respiratory failure. Adv Shock Res (1980) 0.78

Differences in eicosanoid and cytokine production between injury/hemorrhage and bacteremic shock in the pig. Shock (1997) 0.78

Leukocyte aggregation response to quantitative plasma levels of C3a and C5a. Arch Surg (1986) 0.77

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group. Am J Surg (1997) 0.77

Prostaglandin and complement interaction in clinical acute respiratory failure. Arch Surg (1986) 0.77

Ketoconazole: a thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma. J Surg Res (1988) 0.77

Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Head Neck Surg (1986) 0.77

Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg (2000) 0.76

Thromboxane and prostacyclin in clinical acute respiratory failure. J Surg Res (1985) 0.76

Neonatal homicide following Roe v Wade. JAMA (1992) 0.75

Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis. Ann Surg (1997) 0.75

Hyperbaric oxygen in systemic inflammation ... HBO is not just a movie channel anymore. Crit Care Med (1998) 0.75

Crush syndrome with death following pneumatic antishock garment application. J Trauma (1984) 0.75

Hemodynamic effect of prostacyclin (PGI2) in acute hypoxic respiratory failure. Surg Forum (1979) 0.75

The hemodynamic effect of profound hypercapnia on acute hypoxic respiratory failure. Circ Shock (1983) 0.75

Reconstruction of the anterior mandible: a preliminary report. Compendium (1988) 0.75

Microbial filtrates activate granulocytes without complement or prostaglandins. Circ Shock (1986) 0.75

The effect of hemorrhagic shock on plasma amino acids and tissue energy substrates in the primate. Am Surg (1979) 0.75

Pilot study of cytokines in emergency department patients with systemic inflammatory response syndrome. Acad Emerg Med (1997) 0.75

The effect of radiofrequency hyperthermia on the Ca755 murine adenocarcinoma. Cancer (1980) 0.75

Nd:YAG laser scalpel compared with conventional techniques in head and neck cancer surgery. Lasers Surg Med (1994) 0.75

Permeability of the shocked cell to ATP-MgCl2. Surg Forum (1979) 0.75

Thromboxane A2 Mediates Hemodynamic and Respiratory Dysfunction in Graded Bacteremia. Surgery (1989) 0.75

Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. Surgery (1986) 0.75

Pathophysiologic plasma levels of leukotriene C4 in relation to the hemodynamic dysfunction and mediator release of graded bacteremia. Shock (1997) 0.75

Prostacyclin is neither sufficient alone nor necessary to cause pulmonary dysfunction: results from infusions of prostacyclin and antiprostacyclin antibody in porcine septic shock. Crit Care Med (2001) 0.75

Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery (1988) 0.75

Quantitative analysis of organ tissue damage after septic shock. Am Surg (2007) 0.75

Thromboxane interaction with cardiopulmonary dysfunction in graded bacterial sepsis. J Trauma (1984) 0.75

Efficacy of jejunogram after jejunostomy insertion. Am Surg (1999) 0.75

Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. Ann Plast Surg (1988) 0.75

Interaction of thromboxane A2 and tissue pathology during graded bacteremia. J Trauma (1987) 0.75

Molecular structural requirements for binding and activation of L-alanine taste receptors. Amino Acids (1993) 0.75

Laser-assisted laparoscopic lumbar diskectomy. N J Med (1994) 0.75

Increased tissue glucose: an unusual response to shock in the nutria. Curr Surg (1979) 0.75

Standard T-tube cholangiogram: a safe method of cholangiography. Bacteremia is an unlikely event after T-tube cholangiography. R I Med J (1985) 0.75

Platelet activating factor mediates cardiopulmonary dysfunction during graded bacteremic shock. J Trauma (1996) 0.75

The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. Shock (2000) 0.75

Prostacyclin and thromboxane A2 in septic shock: species differences. Circ Shock (1986) 0.75

Interleukin-1 mediates hemodynamic dysfunction and release of eicosanoids and tumor necrosis factor during graded bacteremia. Shock (1999) 0.75

Positive pressure respirations and pneumatic antishock garment application--hemodynamic response. J Trauma (1985) 0.75